| 國立政治大學 |
2010 |
A comparison of individual and team research performance: A study of patents in III
|
Hsu, Lien A.;Lee, K.-H.; 徐聯恩 |
| 國立成功大學 |
2022 |
A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors
|
Chan, S.L.;Schuler, M.;Kang, Y.-K.;Yen, C.-J.;Edeline, J.;Choo, S.P.;Lin, C.-C.;Okusaka, T.;Weiss, K.-H.;Macarulla, T.;Cattan, S.;Blanc, J.-F.;Lee, K.-H.;Maur, Maur M.;Pant, S.;Kudo, M.;Assenat, E.;Zhu, A.X.;Yau, T.;Lim, H.Y.;Bruix, J.;Geier, A.;Guill�n-Ponce, C.;Fasolo, A.;Finn, R.S.;Fan, J.;Vogel, A.;Qin, S.;Riester, M.;Katsanou, V.;Chaudhari, M.;Kakizume, T.;Gu, Y.;Porta, D.G.;Myers, A.;Delord, J.-P. |
| 國立臺灣科技大學 |
2010 |
A novel visual secret sharing scheme for multiple secrets without pixel expansion
|
Lin T.-L.; Horng S.-J.; Lee K.-H.; Chiu P.-L.; Kao T.-W.; Chen Y.-H.; Run R.-S.; Lai J.-L.; Chen R.-J. |
| 臺大學術典藏 |
2018-09-10T07:26:19Z |
A sensitive fluorescence in situ hybridization technique for detection of porcine reproductive and respiratory syndrome virus
|
Chueh, L.-L.; Lee, K.-H.; Jeng, C.-R.; Pang, V.F.; Chueh, L.-L.; Lee, K.-H.; Jeng, C.-R.; Pang, V.F.; CHIAN-REN JENG; VICTOR FEI PANG |
| 臺大學術典藏 |
2019-08-14T05:59:21Z |
A sensitive fluorescence in situ hybridization technique for detection of porcine reproductive and respiratory syndrome virus.
|
Chueh, L. L.; Lee, K. H.; Jeng, C. R.; Pang, V. F.Chian-Ren Jeng; CHIAN-REN JENG; Chueh, L. L.; Lee, K. H.; Jeng, C. R.; Pang, V. F. |
| 臺大學術典藏 |
2018-09-10T08:30:27Z |
A unique P-glycoprotein interacting agent displays anticancer activity against hepatocellular carcinoma through inhibition of GRP78 and mTOR pathways
|
Kuo, T.-C.;Chiang, P.-C.;Yu, C.-C.;Nakagawa-Goto, K.;Bastow, K.F.;Lee, K.-H.;Guh, J.-H.; JIH-HWA GUH |
| 臺大學術典藏 |
2020-12-28T05:56:09Z |
A unique P-glycoprotein interacting agent displays anticancer activity against hepatocellular carcinoma through inhibition of GRP78 and mTOR pathways
|
Guh J.-H.; Bastow K.F.; Lee K.-H.; Nakagawa-Goto K.; Yu C.-C.; Chiang P.-C.; TING-CHUN KUO |
| 臺大學術典藏 |
2021-06-02T05:43:49Z |
A unique P-glycoprotein interacting agent displays anticancer activity against hepatocellular carcinoma through inhibition of GRP78 and mTOR pathways
|
Kuo T.-C.; Chiang P.-C.; Yu C.-C.; Nakagawa-Goto K.; Bastow K.F.; Lee K.-H.; JIH-HWA GUH |
| 國立臺灣科技大學 |
2010 |
A visual sharing scheme for multiple secrets by camouflaging process
|
Lin T.-L.; Horng S.-J.; Lee K.-H.; Chiu P.-L.; Kao T.-W.; Run R.-S.; Lai J.-L.; Chen R.-J. |
| 臺大學術典藏 |
2020-02-03T08:43:40Z |
Acoustic differentiation and behavioral response reveals cryptic species within Buergeria treefrogs (Anura, Rhacophoridae) from Taiwan
|
Wang Y.-H.; Hsiao Y.-W.; Lee K.-H.; Tseng H.-Y.; Lin Y.-P.; Komaki S.; Lin S.-M.; HUI-YUN TSENG |
| 國立臺灣大學 |
2015 |
Afatinib (A) versus chemotherapy (CT) for EGFR mutation-positive NSCLC patients (pts) aged >= 65 years: Subgroup analyses of LUX-Lung 3 (LL3) and LUX-Lung 6 (LL6)
|
Wu, Y. -L.; Sequist, L. V.; Geater, S. L.; Orlov, S.; Lee, K. H.; Tsai, C. -M.; Kato, T.; Kiura, K.; Barrios, C. H.; Schuler, M.; Hirsh, V.; Yamamoto, N.; O'Byrne, K.; Mok, T.; Massey, D.; Maerten, A.; Yang, J. C. -H.; 楊志新 |
| 臺大學術典藏 |
2020-05-26T09:26:27Z |
Afatinib as First-line Treatment of Older Patients With EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Subgroup Analyses of the LUX-Lung 3, LUX-Lung 6, and LUX-Lung 7 Trials
|
Park K.;Paz-Ares L; Chih-Hsin Yang;M?rten A;Peil B;Mok T;Boyer M;O'Byrne K;Yamamoto N;Hirsh V;Schuler M;Barrios C.H;Kato T;Tsai C.-M;Lee K.H;Zhang L;Orlov S;Geater S.L;Tan E.-H;Sequist L.V;Wu Y.-L; Wu Y.-L; Sequist L.V; Tan E.-H; Geater S.L; Orlov S; Zhang L; Lee K.H; Tsai C.-M; Kato T; Barrios C.H; Schuler M; Hirsh V; Yamamoto N; O'Byrne K; Boyer M; Mok T; Peil B; Märten A; Chih-Hsin CHIH-HSIN YANG; Paz-Ares L; Park K. |
| 臺大學術典藏 |
2020-05-26T09:26:54Z |
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): Analysis of overall survival data from two randomised, phase 3 trials
|
Sequist L.V.;Zazulina V;Shahidi M;Massey D;Kato T;Lee K.H;Su W.-C;Boyer M;Mok T;Orlov S;Bennouna J;Hirsh V;Gorbunova V;Tsai C.-M;Lee K.Y;Geater S.L;Huang Y;Lu S;Feng J;O'Byrne K;Hu C.-P;Zhou C;Yamamoto N;Popat S;Sebastian M;Schuler M;Wu Y.-L;Chih-Hsin Yang; CHIH-HSIN YANG; Wu Y.-L; Schuler M; Sebastian M; Popat S; Yamamoto N; Zhou C; Hu C.-P; O'Byrne K; Feng J; Lu S; Huang Y; Geater S.L; Lee K.Y; Tsai C.-M; Gorbunova V; Hirsh V; Bennouna J; Orlov S; Mok T; Boyer M; Su W.-C; Lee K.H; Kato T; Massey D; Shahidi M; Zazulina V; Sequist L.V. |
| 臺大學術典藏 |
2020-05-26T09:26:45Z |
Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): A phase 2B, open-label, randomised controlled trial
|
Paz-Ares L.;Zazulina V;Massey D;Kim M;Shahidi M;Tsai C.-M;Laurie S.A;K?lbeck K;Arvis C.D;Kim D.-W;Laskin J;Kim S.-W;Shi Y;Lu S;Lee K.H;Chih-Hsin Yang;Hirsh V;Mok T;Boyer M;Zhang L;O'Byrne K;Tan E.-H;Park K; Park K; Tan E.-H; O'Byrne K; Zhang L; Boyer M; Mok T; Hirsh V; CHIH-HSIN YANG; Lee K.H; Lu S; Shi Y; Kim S.-W; Laskin J; Kim D.-W; Arvis C.D; Kölbeck K; Laurie S.A; Tsai C.-M; Shahidi M; Kim M; Massey D; Zazulina V; Paz-Ares L. |
| 臺大學術典藏 |
2020-05-26T09:26:42Z |
Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: Overall survival data from the phase IIb LUX-Lung 7 trial
|
Mok T; Lee K.H; Lu S; Shi Y; Lee D.H; Laskin J; Kim D.-W; Laurie S.A; Kölbeck K; Fan J; Dodd N; Märten A; Park K.; Park K.;M?rten A;Dodd N;Fan J;K?lbeck K;Laurie S.A;Kim D.-W;Laskin J;Lee D.H;Shi Y;Lu S;Lee K.H;Mok T;Chih-Hsin Yang;Boyer M;Hirsh V;Zhang L;O'Byrne K;Tan E.-H;Paz-Ares L; Paz-Ares L; Tan E.-H; O'Byrne K; Zhang L; Hirsh V; Boyer M; CHIH-HSIN YANG |
| 國立成功大學 |
2009 |
Al0.25Ga0.75N/GaN Schottky Barrier Photodetectors with an Al0.3Ga0.7N Intermediate Layer
|
Lee, K. H.; Chang, Ping-Chuan; Chang, Shoou-Jinn; Su, Yan-Kuin; Wang, Y. C.; Yu, C. L.; Wu, S. L. |
| 國立成功大學 |
2012 |
AlGaN/GaN Heterostructure Field-Effect Transistor with Semi-Insulating Mg-Doped GaN Cap Layer
|
Lee, K. H.; Chang, P. C.; Chang, S. J. |
| 國立成功大學 |
2012-06 |
AlGaN/GaN heterostructure field-effect transistors with multi-MgxNy/GaN buffer and Photo-CVD SiO2 gate dielectric
|
Lee, K. H.; Chang, P. C.; Chang, S. J.; Su, Y. K. |
| 國立成功大學 |
2014 |
AlGaN/GaN High Electron Mobility Transistors with Multi-MgxNy/GaN Buffer
|
Chang, P. C.; Lee, K. H.; Wang, Z. H.; Chang, S. J. |
| 國立成功大學 |
2011-10-10 |
AlGaN/GaN metal-insulator-semiconductor heterostructure field-effect transistor with an in-situ AlN cap layer
|
Lee, K. H.; Chang, P. C.; Chang, S. J. |
| 國立成功大學 |
2008 |
AlGaN/GaN Schottky barrier diodes with multi-MgxNy/GaN buffer
|
Lee, K. H.; Chang, Shoou-Jinn; Chang, Ping-Chuan; Wang, Y. C.; Kuo, C. H. |
| 國立成功大學 |
2009-01 |
AlGaN/GaN Schottky Barrier Photodetector With Multi-MgxNy/GaN Buffer
|
Chang, Shoou-Jinn; Lee, K. H.; Chang, Ping-Chuan; Wang, Y. C.; Kuo, C. H.; Wu, S. L. |
| 國立成功大學 |
2009-07 |
AlGaN/GaN Schottky Barrier UV Photodetectors With a GaN Sandwich Layer
|
Lee, K. H.; Chang, Ping-Chuan; Chang, Shoou-Jinn; Wang, Y. C.; Yu, Chia-Lin; Wu, San-Lein |
| 國立成功大學 |
2009-10 |
AlGaN/GaN two-dimensional electron gas Schottky barrier photodiodes with multiple MgxNy/GaN layers
|
Chang, Ping-Chuan; Lee, K. H.; Chang, Shoou-Jinn; Su, Yan-Kuin; Liu, C. H. |
| 臺大學術典藏 |
2022-08-10T02:37:39Z |
Amivantamab in egfr exon 20 insertion- mutated non-small-cell lung cancer progressing on platinum chemotherapy: Initial results from the chrysalis phase i study
|
Park K.; Haura E.B.; Leighl N.B.; Mitchell P.; Shu C.A.; Girard N.; Viteri S.; Han J.-Y.; Kim S.-W.; Lee C.K.; Sabari J.K.; Spira A.I.; Yang T.-Y.; Kim D.-W.; Lee K.H.; Sanborn R.E.; Trigo J.; Goto K.; Lee J.-S.; CHIH-HSIN YANG; Govindan R.; Bauml J.M.; Garrido P.; Krebs M.G.; Reckamp K.L.; Xie J.; Curtin J.C.; Haddish-Berhane N.; Roshak A.; Millington D.; Lorenzini P.; Thayu M.; Knoblauch R.E.; Cho B.C. |
